Donald A. Kalkofen

Insider Reports History

Location
Newark, CA
Signature
/s/ Donald A. Kalkofen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Donald A. Kalkofen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protagonist Therapeutics, Inc Chief Financial Officer Common Stock 18,521 $456,172 $24.63 15 Feb 2022 Direct
Protagonist Therapeutics, Inc Chief Financial Officer Stock Option (right to buy) 45,000 15 Feb 2022 Direct

Insider Reports Filed by Donald A. Kalkofen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PTGX Protagonist Therapeutics, Inc 15 Feb 2022 2 $0 4 Chief Financial Officer 17 Feb 2022, 18:26